Trastuzumab decreases the incidence of clinical relapses in patients with early breast cancer presenting chemotherapy-resistant CK-19mRNA-positive circulating tumor cells: results of a randomized phase II studyVasilis Georgoulias, D. Mavroudis|Annals of Oncology|2012Cited by 150